carbogen has been researched along with Necrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhury, A; Hoskin, PJ; Irlam, J; Lane, B; Mistry, H; Song, YP; Valentine, H; West, C; Yang, L | 1 |
| Agrawal, S; Choudhury, A; Denley, H; Eustace, A; Harris, AL; Hoskin, PJ; Irlam, JJ; Ord, JJ; Rojas, AM; Ryder, D; Taylor, J; West, CM | 1 |
| Biessen, EA; Cleutjens, JP; Daemen, MJ; Demandt, JA; Donners, MM; Dubois, LJ; Fisher, EA; Gijbels, MJ; Haenen, GR; Heemskerk, JW; Janssen, A; Janssen, BJ; Jeurissen, M; Lambin, P; Mallat, Z; Marsch, E; Meex, SJ; Schalkwijk, CG; Sluimer, JC; Theelen, TL; van Gink, M; Verjans, R | 1 |
| McPhail, LD; Robinson, SP | 1 |
| Baker, JH; Huxham, LA; Kyle, AH; McNicol, KL; Minchinton, AI | 1 |
| Guichard, M; Prade, M; Thomas, CD | 1 |
2 trial(s) available for carbogen and Necrosis
| Article | Year |
|---|---|
Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399).
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carbon Dioxide; Confidence Intervals; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Necrosis; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Regression Analysis; Survival Rate; Time Factors; Treatment Outcome; Tumor Hypoxia; Urinary Bladder Neoplasms | 2021 |
Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.
Topics: Aged; Aged, 80 and over; Carbon Dioxide; Carbonic Anhydrase IV; Cell Hypoxia; Female; Glucose Transporter Type 1; Humans; Male; Middle Aged; Necrosis; Niacinamide; Oxygen; Risk; Urinary Bladder Neoplasms | 2013 |
4 other study(ies) available for carbogen and Necrosis
| Article | Year |
|---|---|
Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
Topics: Animals; Apoptosis; c-Mer Tyrosine Kinase; Carbon Dioxide; CD36 Antigens; Humans; Hypoxia; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Oxygen; Phagocytosis; Plaque, Atherosclerotic; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Receptors, LDL | 2014 |
Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis.
Topics: Animals; Biomarkers, Tumor; Carbon Dioxide; Female; Fibrosis; Hypoxia; Keratin-14; Linear Models; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Methylnitrosourea; Necrosis; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Rats; Rats, Wistar | 2010 |
Exploring vascular dysfunction caused by tirapazamine.
Topics: Animals; Antineoplastic Agents; Carbon Dioxide; Cell Hypoxia; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; HCT116 Cells; Humans; Mice; Mice, Inbred C3H; Mice, Inbred NOD; Mice, SCID; Necrosis; Neoplasms, Experimental; Nitric Oxide Synthase; Nitroarginine; Oxygen; Regional Blood Flow; Time Factors; Tirapazamine; Triazines | 2008 |
Tumour oxygenation, radiosensitivity, and necrosis before and/or after nicotinamide, carbogen and perflubron emulsion administration.
Topics: Animals; Carbon Dioxide; Cell Survival; Fluorocarbons; Humans; Hydrocarbons, Brominated; Hypoxia; Mice; Necrosis; Niacinamide; Oxygen; Tumor Cells, Cultured | 1995 |